Brief: Zevra Therapeutics Announces Resubmission Of New Drug Application To The U.S. FDA

Zevra Therapeutics

27/12/2023 13:25

Dec 27 (Reuters) - Zevra Therapeutics Inc  ZVRA.O :
    * ZEVRA THERAPEUTICS ANNOUNCES RESUBMISSION OF ARIMOCLOMOL
NEW
DRUG APPLICATION TO THE U.S. FOOD AND DRUG ADMINISTRATION
    * ZEVRA THERAPEUTICS ANNOUNCES RESUBMISSION OF ARIMOCLOMOL
NEW
DRUG APPLICATION TO THE U.S. FOOD AND DRUG ADMINISTRATION
    * ZEVRA THERAPEUTICS INC-EXPECTS NDA TO BE CLASSIFIED AS A
CLASS
II SUBMISSION
    * ZEVRA THERAPEUTICS INC-SETTING PDUFA DATE IS EXPECTED
WITHIN 30
DAYS

Source text for Eikon:  ID:nGNX66d4Kw 
Further company coverage:  ZVRA.O 

 ((Reuters.Briefs@thomsonreuters.com;))